Compounding semaglutide allows personalized formulations for patients that are not commercially available
Can I use this combination long-term
In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
Adults typically need 2.4 mcg per day (which goes up to 2.6 and 2.8 mcg per day if pregnant or breastfeeding, respectively)
Each batch is produced under validated synthesis protocols to ensure consistency and reproducibility
For women, it supports healthy ovulation and embryo development